Promoting myelin repair in the brain

Dr Simon Murray

The University of Melbourne, VIC

| A cure via repair and regeneration | Neurobiology | Project | 2019 | Investigator Led Research |
SUPPORT PROJECTS WITH THIS RESEARCH FOCUS

Summary

Methods to promote the rebuilding of myelin after myelin loss are essential to prevent the progression of disability in MS. Dr Simon Murray and his team have identified that a growth factor produced in the brain called brain-derived neurotrophic factor (BDNF), promotes myelination during early development of the brain. They believe it may also be useful to help maintain and repair myelin after injury in the adult brain.

Dr Murray and his team have been using a compound which copies the actions of BDNF and have shown that it promotes myelin renewal in basic laboratory models of MS. This project will take the next step in this line of research to see if the compound can promote myelin repair in an environment which more closely mirrors the situation we see in people with MS. They will use a more complex model of myelin damage: where spontaneous remyelination does not occur and where there have been repeated episodes of myelin loss, reflecting the conditions that might occur in people with MS.

The outcome of this project will help identify whether this compound might ultimately be useful as a drug to stimulate myelin repair in people with MS.

Updated: 23 January 2019

Updated: 05 January, 2019

Stages of the research process

Fundamental laboratory
Research

Laboratory research that investigates scientific theories behind the possible causes, disease progression, ways to diagnose and better treat MS.

Lab to clinic timeline: 10+ years
Translational
Research

Research that builds on fundamental scientific research to develop new therapies, medical procedures or diagnostics and advances it closer to the clinic.

Lab to clinic timeline: 5+ years
Clinical Studies
and Clinical Trials

Clinical research is the culmination of fundamental and translational research turning those research discoveries into treatments and interventions for people with MS.

Lab to clinic timeline: 1-5 years

Investigator

Co-investigator

Grant Awarded

  • Project Grant

Total Funding

  • $143,400

Duration

  • 2 years - starting 2019

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search